Literature DB >> 7439224

Serum CEA monitoring in the follow-up of colorectal cancer patients with negative preoperative serum CEA.

G Mariani, M Carmellini, F Bonaguidi, M A Benelli, M G Toni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7439224     DOI： 10.1016/0014-2964(80)90259-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  The serum level of carcinoembryonic antigen in drainage venous blood is not a sensitive predictor of metachronous hepatic metastasis for patients with colorectal cancer.

Authors:  Masashi Haraguchi; Fumihiko Fujita; Yasuhiro Torashima; Takamitsu Inokuma; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

2.  Accuracy of monitoring serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is limited to only the first postoperative year.

Authors:  Masayasu Hara; Mikinori Sato; Hiroki Takahashi; Satoru Takayama; Hiromitsu Takeyama
Journal:  Surg Today       Date:  2011-09-16       Impact factor: 2.549

3.  [Effect of serial CEA determination on diagnosis, therapy and prognosis of recurrent colorectal cancer].

Authors:  B Mentges
Journal:  Langenbecks Arch Chir       Date:  1988

4.  The potential role of ORM2 in the development of colorectal cancer.

Authors:  Xuhua Zhang; Zhiying Xiao; Xiaoyong Liu; Lutao Du; Lili Wang; Shun Wang; Ni Zheng; Guixi Zheng; Wei Li; Xin Zhang; Zhaogang Dong; Xuewei Zhuang; Chuanxin Wang
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 5.  Blood CEA levels for detecting recurrent colorectal cancer.

Authors:  Brian D Nicholson; Bethany Shinkins; Indika Pathiraja; Nia W Roberts; Tim J James; Susan Mallett; Rafael Perera; John N Primrose; David Mant
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.